Related Articles
Potential role for pentoxifylline as an anti‑inflammatory drug for patients with acute coronary syndrome
Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease
Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
Spontaneous intermuscular hematoma in a patient receiving ticagrelor and aspirin: A case report
Rosuvastatin plus ticagrelor decreases the risk of major adverse cardiovascular events and elevates cardiac function compared with ticagrelor alone in patients undergoing percutaneous coronary intervention: A meta‑analysis